title: Use of Urgotul SSD to reduce bacteria and promote healing in chronic wounds.
abstract: This product focus seeks to give an overview of the management of wound bioburden in relation to the use of antimicrobial dressings, according to recent guidelines and best practice statements. Identification of critical colonisation/localised infection and the role of biofilms is a key aspect of effective wound management. Silver antimicrobial dressings are efficient in reducing bacteria in wounds, but must be used appropriately to prevent overuse. Silver sulphadiazine has traditionally been used for the treatment of burns or Pseudomonas infection in leg ulceration, often in a cream formation. This article will be looking specifically at the effective use of Urgotul SSD in three critically colonised/non healing wounds.
authors.affiliation: Enfield Community Services, Barnet, Enfield. annette.downe@enfield.nhs.uk
authors.forename: Annette
authors.initials: A
authors.lastname: Downe
mesh_terms: D000368:Aged; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001458:Bandages; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy / Q000382:microbiology; D008297:Male; D012837:Silver Sulfadiazine / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects*; D014946:Wound Infection / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000891:Anti-Infective Agents, Local; D012837:Silver Sulfadiazine